YEAR | COMPANY | POSITION | SALARY | INCREMENT |
---|---|---|---|---|
2024 | Oncolytics Biotech, Inc. | Independent Director | 103.4 K | - |
2024 | Aprea Therapeutics Inc | Independent Director | 75.9 K | 29.3 % |
2024 | Aptose Biosciences Inc | Independent Director | - | - |
2023 | Aptose Biosciences Inc | Independent Director | 132.2 K | 191.8 % |
2023 | Aprea Therapeutics Inc | Independent Director | 58.7 K | -32.3 % |
2022 | Oncolytics Biotech, Inc. | Independent Director | 104.1 K | -27.7 % |
2022 | Aprea Therapeutics Inc | Independent Director | 86.8 K | -44.2 % |
2022 | Aptose Biosciences Inc | Independent Director | 45.3 K | - |
2021 | Aprea Therapeutics Inc | Independent Director | 155.4 K | -20.6 % |
2021 | Oncolytics Biotech, Inc. | Independent Director | 143.9 K | 16.2 % |
2020 | Aprea Therapeutics Inc | Independent Director | 195.7 K | 1583.2 % |
2020 | Oncolytics Biotech, Inc. | Independent Director | 123.8 K | 25.2 % |
2019 | Oncolytics Biotech, Inc. | Director | 98.9 K | -6.1 % |
2019 | Aprea Therapeutics Inc | Independent Director | 11.6 K | -59.5 % |
2018 | Oncolytics Biotech, Inc. | Director | 105.4 K | -18.5 % |
2018 | Aprea Therapeutics Inc | Independent Director | 28.7 K | - |
2017 | Oncolytics Biotech, Inc. | Director | 129.3 K | 32.6 % |
2016 | Oncolytics Biotech, Inc. | Director | 97.5 K | 57.7 % |
2015 | Oncolytics Biotech, Inc. | Director | 61.8 K | - |